Characterization of human FHL2 transcript variants and gene expression regulation in hepatocellular carcinoma.

[1]  Wenjing Zhang,et al.  Sp1 upregulates the four and half lim 2 (FHL2) expression in gastrointestinal cancers through transcription regulation , 2010, Molecular carcinogenesis.

[2]  H. Zhang,et al.  Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway. , 2009, The Journal of clinical investigation.

[3]  D. Tindall,et al.  Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer. , 2007, Cancer research.

[4]  U. Moens,et al.  The multifunctional roles of the four-and-a-half-LIM only protein FHL2 , 2006, Cellular and Molecular Life Sciences CMLS.

[5]  Thomas Werner,et al.  MatInspector and beyond: promoter analysis based on transcription factor binding sites , 2005, Bioinform..

[6]  Margaret A. Pericak-Vance,et al.  Statistical Viewer: a tool to upload and integrate linkage and association data as plots displayed within the Ensembl genome browser , 2005, BMC Bioinformatics.

[7]  S. Nicosia,et al.  Suppression of FOXO1 activity by FHL2 through SIRT1‐mediated deacetylation , 2005, The EMBO journal.

[8]  C. Dieterich,et al.  The SRF target gene Fhl2 antagonizes RhoA/MAL-dependent activation of SRF. , 2004, Molecular cell.

[9]  Yu Wei,et al.  Interaction and Functional Cooperation between the LIM Protein FHL2, CBP/p300, and β-Catenin , 2004, Molecular and Cellular Biology.

[10]  P. Riley,et al.  Differential Regulation of Hand1 Homodimer and Hand1-E12 Heterodimer Activity by the Cofactor FHL2 , 2004, Molecular and Cellular Biology.

[11]  R. Schüle,et al.  Focal adhesion kinase interacts with the transcriptional coactivator FHL2 and both are overexpressed in epithelial ovarian cancer. , 2004, Anticancer research.

[12]  R. Schüle,et al.  Extracellular Signal-Regulated Kinase 2 Interacts with and Is Negatively Regulated by the LIM-Only Protein FHL2 in Cardiomyocytes , 2004, Molecular and Cellular Biology.

[13]  D. Fisher,et al.  SKI Activates Wnt/-Catenin Signaling in Human Melanoma1 , 2003 .

[14]  Q. Ye,et al.  BRCA1 interacts with FHL2 and enhances FHL2 transactivation function , 2003, FEBS letters.

[15]  Alexander E. Kel,et al.  MATCHTM: a tool for searching transcription factor binding sites in DNA sequences , 2003, Nucleic Acids Res..

[16]  P. Sassone-Corsi,et al.  The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. Wilhelm,et al.  The LIM-only coactivator FHL2 modulates WT1 transcriptional activity during gonadal differentiation. , 2002, Biochimica et biophysica acta.

[18]  A. Leonardi,et al.  TUCAN/CARDINAL and DRAL participate in a common pathway for modulation of NF‐κB activation , 2002, FEBS letters.

[19]  M. Waye,et al.  Protein–protein interaction of FHL3 with FHL2 and visualization of their interaction by green fluorescent proteins (GFP) two‐fusion fluorescence resonance energy transfer (FRET) , 2001, Journal of cellular biochemistry.

[20]  P. Sassone-Corsi,et al.  A Family of LIM-Only Transcriptional Coactivators: Tissue-Specific Expression and Selective Activation of CREB and CREM , 2000, Molecular and Cellular Biology.

[21]  B. Schäfer,et al.  Dral Is a P53-Responsive Gene Whose Four and a Half Lim Domain Protein Product Induces Apoptosis , 2000, The Journal of cell biology.

[22]  J. Ross,et al.  FHL2 (SLIM3) Is Not Essential for Cardiac Development and Function , 2000, Molecular and Cellular Biology.

[23]  T. Tabira,et al.  Alzheimer's disease-associated presenilin 2 interacts with DRAL, an LIM-domain protein. , 2000, Human molecular genetics.

[24]  I. Bach,et al.  The LIM domain: regulation by association , 2000, Mechanisms of Development.

[25]  R. Schüle,et al.  FHL2, a novel tissue‐specific coactivator of the androgen receptor , 2000, The EMBO journal.

[26]  K P Fung,et al.  Molecular cloning and characterization of FHL2, a novel LIM domain protein preferentially expressed in human heart. , 1998, Gene.

[27]  B. Schäfer,et al.  Subtractive cloning and characterization of DRAL, a novel LIM-domain protein down-regulated in rhabdomyosarcoma. , 1997, DNA and cell biology.

[28]  M. Morgan,et al.  Slim defines a novel family of LIM-proteins expressed in skeletal muscle. , 1996, Biochemical and biophysical research communications.